News
In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...
Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...
The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.
Eli Lilly offers an annual dividend yield of 0.78%. So, how can investors exploit its dividend yield to pocket a regular $500 ...
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...
The US Food and Drug Administration (FDA) has approved a label expansion to Teva’s Ajovy in certain children and adolescents, ...
4h
TipRanks on MSNEli Lilly’s New ALS Study: A Potential Game-Changer for Investors?Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of conspiring to restrict drug discounts offered to community pharmacies that ...
2h
Al Jazeera on MSNWegovy maker Novo Nordisk warns of layoffs as competition growsNovo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be ...
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...
Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results